Broker recommendations: Should you buy Macquarie Group Ltd, Medibank Private Ltd and SEEK Limited?

Is there any value to be found in Macquarie Group Ltd (ASX:MQG), Medibank Private Ltd (ASX:MPL), and SEEK Limited (ASX:SEK)?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investors familiar with recommendations from major broking houses have probably learned to take them with a pinch of salt – I know I do.

However, they can be worth reading as businesses such as Bell Potter, Goldman Sachs, and Deutsche Bank have expertise and research that is generally far beyond what the average investor has access to.

It is important to remember that these recommendations have a one-year time frame and are made by human (and thus fallible) analysts.

Bell Potter recently reconfirmed its Buy rating on Macquarie Group Ltd (ASX: MQG) with a price target of $91.50, declaring that Macquarie's Esanda acquisition was good for the business.

However, the bullish price target reflects quite a short term view and overlooks the potential for weakness in international markets to hurt Macquarie over the long term. I believe that Macquarie is an acceptable buy at today's prices if you've got a long time frame and are willing to tolerate a few cyclical peaks and troughs along the way. It's worth noting that Goldman Sachs is 'neutral' on the stock.

Goldman Sachs is also Neutral on Medibank Private Ltd (ASX: MPL) – lifting its price target 6% to $2.65 – believing that Medibank would focus on reducing growth in the number of claims it receives and that profit margins would improve just 0.3% by financial year 2018.

Medibank has stated previously that a small number of claimants make for most of its claim expenses, and a focus on reducing chronic illness in its customers will be valuable going forwards. In the near term, a Productivity Commission review into the healthcare system has the potential to either help or hurt earnings, depending on which recommendations are adopted.

Goldman Sachs' recommendation looks to be spot-on, although I think there is room for upside over the next few years.

Deutsche Bank left its Hold rating on SEEK Limited (ASX: SEK) and price target of $12 unchanged, pointing out that while SEEK's most recent reported Net Debt / (divided by) EBITDA (Earnings Before Interest, Tax, Depreciation and Amortisation) was a solid 1.3x, the Net Debt/EBITDA applied to the company's domestic operations only is a less comfortable 3x.

In other words, SEEK's net debt is 3 times as large as the 2015 earnings before tax on its domestic operations. Deutsche Bank believes this leaves limited capacity for further investment, which will be a hindrance in light of SEEK's focus on international opportunities.

Like the Goldman Sachs recommendation above, this one makes a fair point. Again it also overlooks the very sizeable international businesses, their potential growth, and network effects of the website as well as the ability to cross-sell related services (like education).

Curiously, of the 13 analysts polled by Nabtrade, 6 recommend buying SEEK, 5 say hold, and 2 say sell. Perhaps more than anything, the take away from today's article is be wary of whose advice you follow when making a purchase.

Motley Fool contributor Sean O'Neill has no position in any stocks mentioned. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »